Home > Healthcare > Biotechnology > Biotechnology R&D > Automated Cell Counter Market
Automated Cell Counter Market Size
- Report ID: GMI5352
- Published Date: Jul 2023
- Report Format: PDF
Automated Cell Counter Market Size
Automated Cell Counter Market size was worth USD 6.3 billion in 2022 and is projected to record over 5.5% CAGR from 2023 to 2032 driven by the rising prevalence of infectious diseases worldwide.
The increasing adoption of unhealthy lifestyles and behaviors, such as alcohol drinking and cigarette smoking along with the subsequently growing incidence of chronic illnesses will drive the market development. According to the WHO, chronic illnesses resulted in more than 71% of all fatalities worldwide. The surging episodes of diabetes, cancer, chronic respiratory ailments, and cardiovascular illnesses have spurred the higher need for sophisticated diagnostic tools, such as automated cell counts.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Automated Cell Counter Market Size in 2022: | USD 6.3 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 5.6% |
| 2032 Value Projection: | USD 10.1 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 160 |
| Tables, Charts & Figures: | 270 |
| Segments covered: | Product Type, Application, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
The lack of skilled labor and the significantly impeding efforts to achieve health-related development goals throughout the world along with the slowing progress of universal health care may limit the market gains. It is estimated that there would be a shortage of 12.9 million healthcare workers worldwide by 2035. However, the continued government measures to provide professional skill-based education and training will assist in overcoming this industry constraint.
Frequently Asked Questions (FAQ) :
Automated Cell Counter Market Scope
